Coleman's office said the event at the Life Learning Center will reveal one of the largest opioid settlements in recent ...
Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...